Medtronic Announces Executive & Board Changes
Ticker: MDT · Form: 8-K · Filed: 2024-06-04T00:00:00.000Z
Sentiment: neutral
Topics: executive-changes, board-of-directors, governance
Related Tickers: MDT
TL;DR
Medtronic shakes up board and execs, effective June 1st.
AI Summary
Medtronic plc announced on June 4, 2024, changes in its executive team and board of directors, effective June 1, 2024. Specifically, Robert L. Taiclet has been appointed as a new Class III Director, and the company has also updated its compensatory arrangements for certain officers.
Why It Matters
Changes in board composition and executive roles can signal shifts in company strategy or governance, impacting investor confidence and future performance.
Risk Assessment
Risk Level: low — The filing details routine corporate governance changes and executive appointments, which typically carry low immediate risk.
Key Players & Entities
- Medtronic plc (company) — Filing company
- Robert L. Taiclet (person) — Newly appointed Class III Director
- June 1, 2024 (date) — Effective date of changes
- June 4, 2024 (date) — Filing date
FAQ
Who has been appointed as a new director at Medtronic plc?
Robert L. Taiclet has been appointed as a new Class III Director.
When were the announced changes effective?
The changes were effective as of June 1, 2024.
What type of filing is this for Medtronic plc?
This is a Form 8-K filing.
What are the main items covered in this 8-K filing?
The filing covers the departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers.
What is Medtronic plc's standard industrial classification?
Medtronic plc's standard industrial classification is ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845].
From the Filing
0001613103-24-000064.txt : 20240604 0001613103-24-000064.hdr.sgml : 20240604 20240604163754 ACCESSION NUMBER: 0001613103-24-000064 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20240601 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers FILED AS OF DATE: 20240604 DATE AS OF CHANGE: 20240604 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Medtronic plc CENTRAL INDEX KEY: 0001613103 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 000000000 FISCAL YEAR END: 0426 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-36820 FILM NUMBER: 241018766 BUSINESS ADDRESS: STREET 1: 20 ON HATCH, LOWER HATCH STREET CITY: DUBLIN STATE: L2 ZIP: 2 BUSINESS PHONE: 01135314381700 MAIL ADDRESS: STREET 1: 20 ON HATCH, LOWER HATCH STREET CITY: DUBLIN STATE: L2 ZIP: 2 FORMER COMPANY: FORMER CONFORMED NAME: Medtronic Ltd DATE OF NAME CHANGE: 20150112 FORMER COMPANY: FORMER CONFORMED NAME: Medtronic Holdings Ltd DATE OF NAME CHANGE: 20140711 FORMER COMPANY: FORMER CONFORMED NAME: Kalani I Ltd DATE OF NAME CHANGE: 20140709 8-K 1 mdt-20240601.htm 8-K mdt-20240601 0001613103 Medtronic plc D02 XH02 false 0001613103 2024-06-01 2024-06-01 0001613103 us-gaap:CommonStockMember 2024-06-01 2024-06-01 0001613103 mdt:SeniorNotes2019Due2025Member 2024-06-01 2024-06-01 0001613103 mdt:SeniorNotes2020Due2025Member 2024-06-01 2024-06-01 0001613103 mdt:SeniorNotesDue2025Member 2024-06-01 2024-06-01 0001613103 mdt:SeniorNotes2019Due2027Member 2024-06-01 2024-06-01 0001613103 mdt:SeniorNotes2020Due2028Member 2024-06-01 2024-06-01 0001613103 mdt:SeniorNotesDue2028Member 2024-06-01 2024-06-01 0001613103 mdt:SeniorNotes2019Due20311.625PercentMember 2024-06-01 2024-06-01 0001613103 mdt:SeniorNotes2019Due20311.00PercentMember 2024-06-01 2024-06-01 0001613103 mdt:SeniorNotesDue2031Member 2024-06-01 2024-06-01 0001613103 mdt:SeniorNotes2020Due2032Member 2024-06-01 2024-06-01 0001613103 mdt:SeniorNotesDue2034Member 2024-06-01 2024-06-01 0001613103 mdt:SeniorNotes2019Due20392.250PercentMember 2024-06-01 2024-06-01 0001613103 mdt:SeniorNotes2019Due20391.50PercentMember 2024-06-01 2024-06-01 0001613103 mdt:SeniorNotes2020Due2040Member 2024-06-01 2024-06-01 0001613103 mdt:SeniorNotes2019Due2049Member 2024-06-01 2024-06-01 0001613103 mdt:SeniorNotes2020Due2050Member 2024-06-01 2024-06-01 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   _____________________________  FORM 8-K   _____________________________  CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 1, 2024   _____________________________  Medtronic plc (Exact name of Registrant as Specified in its Charter)    _____________________________    Ireland   1-36820   98-1183488 (State or other jurisdiction of incorporation)   (Commission File Number)   (IRS Employer Identification No.) 20 On Hatch, Lower Hatch Street Dublin 2 , Ireland (Address of principal executive offices) (Zip Code) + 353 1 438-1700 (Registrant’s telephone number, including area code) Not Applicable Former name or former address, if changed since last report Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under th